Trials / Completed
CompletedNCT00345371
Topiramate for the Treatment of Methamphetamine Dependence - 1
Phase 2, Double-Blind, Placebo-Controlled Trial of Topiramate for the Treatment of Methamphetamine Dependence
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy and safety of topiramate as compared to placebo in reducing methamphetamine use in subjects with methamphetamine dependence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Topiramate | |
| DRUG | Placebo Oral Tablet |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2008-08-01
- Completion
- 2008-12-01
- First posted
- 2006-06-28
- Last updated
- 2017-03-27
- Results posted
- 2017-02-23
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00345371. Inclusion in this directory is not an endorsement.